On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayMar 18, 2024 11:55 am

CannabisNewsBreaks – BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) Announces Closing of $7M Underwritten Public Offering

BYND Cannasoft (NASDAQ: BCAN) (CSE: BYND), an Israeli-based integrated software and cannabis company, recently announced the closing of a firm commitment underwritten public offering with gross proceeds to the company of approximately $7.0 million. BYND Cannasoft expects to use the net proceeds from the offering for general corporate purposes and working capital. In addition, the company has granted Aegis Capital Corp. a 45-day option to purchase up to an additional 15% of the total number of common shares and/or pre-funded warrants and/or Series A warrants and/or Series B warrants sold in the offering, solely to cover over-allotments, if any. On…

Continue Reading

FridayMar 15, 2024 12:14 pm

CannabisNewsBreaks – The Cannabis Place Opens Its New York City Flagship State-Licensed Dispensary in Middle Village Area

The Cannabis Place, a licensed adult-use dispensary operator in New York and New Jersey, is reporting the grand opening of its New York City flagship licensed dispensary. The location at 74-03 Metropolitan Avenue, Middle Village in Queens, will open its doors on Saturday, March 16, at 4.20 p.m. ET. “We picked this weekend to open because it’s symbolic in many ways. By opening our state-licensed dispensary in the Middle Village area of New York City, we are providing New Yorkers with access to licensed and regulated New York Cannabis products,” said Osbert Orduña, The Cannabis Place founder and CEO. “We…

Continue Reading

FridayMar 15, 2024 11:42 am

CannabisNewsBreaks – Tether Curates Series of Events for Its Third Annual Budtender Appreciation Week

Tether, a leading name in the Canadian cannabis industry, has curated a week-long series of opportunities, including retail visits and educational sampling events, as part of the upcoming third annual Budtender Appreciation Week. “B-Week,” an initiative created to recognize and celebrate the contributions of cannabis retail workers across Canada, is set for March 24 through March 31, 2024, promising to be bigger than ever, featuring sampling events in Vancouver, British Columbia, Oakville, Ontario, and Edmonton, Alberta. “Green Hedge and our portfolio of brands are proud to be part of Tether’s Budtender Appreciation Week at events across Canada,” said Steve Crichton,…

Continue Reading

ThursdayMar 14, 2024 3:07 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as senior vice president of finance and operations at Rain Oncology Inc., a late-stage precision oncology biotech company. In that position, he was pivotal in building and leading the company’s financial organization, resulting in significant growth…

Continue Reading

TuesdayMar 12, 2024 2:17 pm

CannabisNewsBreaks — Zoned Properties Inc. (ZDPY) Chooses IBN as Corporate Communications Partner

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry, is partnering with IBN, a multifaceted financial news and publishing company for private and public entities. According to the announcement, IBN will assist Zoned Properties with its corporate communications initiatives and help strengthen awareness of the company. Zoned Properties is focused on innovating in the real-estate development space, and is working to redefining the way people invest in commercial real estate. Zoned Properties offers a proprietary national ecosystem of real estate services, including a commercial real estate brokerage and a…

Continue Reading

ThursdayMar 07, 2024 2:03 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO for Second DehydraTECH-Powered GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to perform the company’s second DehydraTECH-powered glucagon-like peptide 1 (“GLP-1”) human pilot study #2. According to the announcement, the study will be a randomized, crossover, placebo-controlled investigation that will compare three formulations, each at a 7 mg semaglutide dose: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. “DehydraTECH has previously shown an ability to improve delivery of certain drugs destined for the bloodstream, through the…

Continue Reading

WednesdayMar 06, 2024 1:36 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (SFWJ) Expands Portfolio, Marking Major Step Toward World-Leading Integration

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) today announced the successful acquisition of two additional companies, expanding its portfolio to nine innovative enterprises. According to the announcement, the strategic expansion includes a company with a critical cannabis genetics license and another with comprehensive licenses to produce, process and export cannabis products. “These acquisitions represent a monumental step towards our vision of becoming a world-leading integrated cannabis company,” said Jose Gabriel Diaz, CEO of MedCana. “With seven cannabis producing companies, one agriculture technology and infrastructure company, and one software company under our belt, MedCana is exceptionally positioned to innovate, produce and…

Continue Reading

TuesdayMar 05, 2024 3:27 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Commence Diabetes and Weight Loss Animal Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced details for an eight-week animal study, WEIGHT-A24-1, to examine diabetes and weight loss effects of DehydraTECH-processed glucagon-like peptide 1 (“GLP-1”) drugs and DehydraTECH-processed cannabidiol, alone and in combination. The contract for the study was awarded to a third-party, Health Canada-licensed research laboratory. Manufacturing of the compositions for the first eight of the 12 study arms has been completed, and those arms will commence as soon as possible at the testing laboratory, expected to begin within 45 days. Each arm of the study will be dosed for…

Continue Reading

TuesdayMar 05, 2024 1:36 pm

CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Marks Pivotal Step in Scaling D2C Real Estate Portfolio

Zoned Properties (OTCQB: ZDPY), a technology driven property investment company for emerging and highly regulated industries, including legalized cannabis, today announced that it has listed its cultivation property in Chino Valley, Arizona (the “Chino Valley Property”) for sale at a purchase price of $16 million. The potential transaction marks a significant development in the company’s strategic real estate portfolio optimization. “As part of our ongoing strategic review to enhance shareholder value, we are very pleased to announce our intention to sell our Chino Valley Property. The Chino Valley Property, which we now consider a non-core asset to our investment strategy,…

Continue Reading

MondayMar 04, 2024 1:08 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Weight-Loss Results in Animal Study, Begins Eight-Week Follow-Up Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting glucose reduction and weight-loss results in a testing of its wholly owned and patented DehydraTECH-CBD formulation. According to the announcement, when administered to rodents in an eight-week study, DehydraTech-CBD resulted in weight loss of 7% and a reduction of 19.9% (p<0.05) in blood glucose. As a result, Lexaria has now signed contracts to begin a large, multiweek animal study that will substantially progress its DehydraTECH-GLP-1 and DehydraTECH-CBD weight-loss investigations. In addition, the announcement also noted that the company had published results of a human study, which showed that a single…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722